Raf-1 and Bcl-2 induce distinct and common pathways that contribute to breast cancer drug resistance

Clinical Cancer Research

Volumn 9, Issue 3, 2003, Pages 1161-1170

  Davis, Julianne M ^a   Navolanic, Patrick M ^a   Weinstein Oppenheimer, Caroline R ^b   Steelman, Linda S ^a   Hu, Wei ^c   Konopleva, Marina ^c   Blagosklonny, Mikhail V ^d   McCubrey, James A ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

^b UNIVERSIDAD DE VALPARAÍSO   (Chile)

^c UNIVERSITY OF TEXAS   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; GLYCOPROTEIN P; MESSENGER RNA; PACLITAXEL; PROTEIN BCL 2; RAF PROTEIN;

ARTICLE; BREAST CARCINOMA; CANCER RESISTANCE; CELL PROLIFERATION; CELL STRAIN MCF 7; CONTROLLED STUDY; CORRELATION ANALYSIS; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN INDUCTION;

ANTINEOPLASTIC AGENTS; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL DIVISION; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; HUMANS; INHIBITORY CONCENTRATION 50; P-GLYCOPROTEIN; PHOSPHORYLATION; PROTEIN ISOFORMS; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTO-ONCOGENE PROTEINS C-RAF; RETROVIRIDAE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; TESTOSTERONE; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 0037342272     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Frankel, A. E., McCubrey, J. A., Miller, M. S., Delatte, S., Ramage, J., Kiser, M., Kucera, G. L., Alexander, R. L., Beran, M., Tagge, E. P., Kreitman, R. J., and Hogge, D. E. Diptheria toxin fused to human interleukin-3 is toxic to blasts from patients with myeloid leukemias. Leukemia, 14: 576-585, 2000.
2. Bredel, M. Anticancer drug resistance in primary human brain tumors. Brain Res. Brain Res. Rev., 35: 161-204, 2001.
3. Chen, Z-S., Aoki, S., Komatsu, M., Ueda, K., Sumizawa, T., Furukawa, T., Okumura, H., Ren, X-Q., Belinsky, M. G., Lee, K., Kruh, G. D., Kobayashi, M., and Akiyama, S. Reversal of drug resistance mediated by multidrug resistance protein (MRP) 1 by dual effects of agosterol A on MRP1 function. Int. J. Cancer, 93: 107-113, 2001.
4. White, M. K., and McCubrey, J. A. Suppression of apoptosis: role in cell growth and neoplasia. Leukemia, 15: 1011-1021, 2001.
5. Sun, S-Y., Yue, P., Zhou, J-Y., Wang, Y., Choi Kim, H-R., Lotan, R., and Wu, G. S. Overexpression of Bcl-2 blocks TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in human lung cancer cells. Biochem. Biophys. Res. Commun., 280: 788-797, 2001.
6. McCubrey, J. A., Blalock, W. L., Chang, F., Steelman, L. S., Pohnert, S. C., Navolanic, P. M., Shelton, J. G., Hoyle, P. E., Moye, P. W., Oberhaus, S. M., White, M. K., Lee, J. T., and Franklin, R. A. Signal transduction pathways: cytokine model. In: M. V. Blagosklonny (ed.), Cell Cycle Checkpoints and Cancer, pp. 17-53. Georgetown, TX: Landes Bioscience, 2001.
7. McCubrey, J. A., Blalock, W. L., Saleh, O., Pearce, M., Burrows, C., Steelman, L. S., Lee, J. T., Franklin, R. A., Oberhaus, S. M., Moye, P. W., Doshi, P. D., and McKearn, J. P. Enhanced ability of daniplestim and myelopoietin-1 to suppress apoptosis in human hematopoietic cells. Leukemia, 15: 1203-1216, 2001.
8. Cory, S. Regulation of lymphocyte survival by the Bcl-2 gene family. Annu. Rev. Immunol., 13: 513-543, 1995.
9. Salveson, G. S., and Dixit, V. M. Caspases: intracellular signaling by proteolysis. Cell, 91: 443-446, 1997.
10. Sato, T., Hanada, M., Bodrug, S., Irie, S., Iwama, N., Boise, L. H., Thompson, C. B., Golemis, E., Fong, L., Wang, H-G., and Reed, J. C. Interactions among members of the Bcl-2 protein family analyzed with a yeast two-hybrid system. Proc. Natl. Acad. Sci. USA, 91: 9238-9242, 1994.
11. Bargou, R. C., Daniel, P. T., Mapara, M. Y., Bommer, K., Wagener, C., Kallinich, B., Royer, H. D., and Dörken, B. Expression of the bcl-2 gene family in normal and malignant breast tissue: low bax-α expression in tumor cells correlates with resistance towards apoptosis. Int. J. Cancer, 60: 854-859, 1995.
12. Hanada, M., Aimé-Sempé, C., Sato, T., and Reed, J. C. Structure-function analysis of Bcl-2 protein. Identification of conserved domains important for homodimerization with Bcl-2 and heterodimerization with Bax. J. Biol. Chem., 270: 11962-11969, 1995.
13. Hunter, J. J., Bond, B. L., and Parslow, T. G. Functional dissection of the human Bcl2 protein: sequence requirements for inhibition of apoptosis. Mol. Cell. Biol., 16: 877-883, 1996.
14. Kroemer, G. The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nat. Med., 3: 614-620, 1997.
15. L-Bak peptide complex: recognition between regulators of apoptosis. Science (Wash. DC), 275: 983-986, 1997.
16. Antoku, K., Maser, R. S., Scully, W. J., Jr., Delach, S. M., and Johnson, D. E. Isolation of Bcl-2 binding proteins that exhibit homology with BAG-1 and suppressor of death domains protein. Biochem. Biophys. Res. Commun., 286: 1003-1010, 2001.
17. H on chromosome 14 and near a transcriptional unit on 18. Cell, 41: 899-906, 1985.
18. Wang, H-G., Takayama, A., Rapp, U. R., and Reed, J. C. Bcl-2 interacting protein, BAG-1, binds to and activates the kinase Raf-1. Proc. Natl. Acad. Sci. USA, 93: 7063-7068, 1996.
19. Franklin, R. A., and McCubrey, J. A. Kinases: positive and negative regulators of apoptosis. Leukemia, 14: 2019-2034, 2000.
20. McCubrey, J. A., Steelman, L. S., Blalock, W. L., Lee, J. T., Moye, P. W., Chang, F., Pearce, M., Shelton, J. G., White, M. K., Franklin, R. A., and Pohnert, S. C. Synergistic effects of PI3K/Akt on abrogation of cytokine-dependency induced by oncogenic Raf. Adv. Enzyme Regul., 41: 289-323, 2001.
21. Weinstein-Oppenheimer, C. R., Burrows, C., Steelman, L. S., and McCubrey, J. A. The effects of β-estradiol on Raf activity, cell cycle progression and growth factor synthesis in the MCF-7 breast cancer cell line. Cancer Biol. Ther., 1: 256-262, 2002.
22. McCubrey, J. A., Steelman, L. S., Hoyle, P. E., Blalock, W. L., Weinstein-Oppenheimer, C., Franklin, R. A., Cherwinski, H., Bosch, E., and McMahon, M. Differential abilities of activated Raf oncoproteins to abrogate cytokine dependency, prevent apoptosis and induce autocrine growth factor synthesis in human hematopoietic cells. Leukemia, 12: 1903-1929, 1998.
23. Blalock, W. L., Weinstein-Oppenheimer, C., Chang, F., Hoyle, P. E., Wang, X-Y., Algate, P. A., Franklin, R. A., Oberhaus, S. M., Steelman, L. S., and McCubrey, J. A. Signal transduction, cell cycle regulatory, and anti-apoptotic pathways regulated by IL-3 in hematopoietic cells: possible sites for intervention with anti-neoplastic drugs. Leukemia, 13: 1109-1166, 1999.
24. McCubrey, J. A., Steelman, L. S., Moye, P. W., Hoyle, P. E., Weinstein-Oppenheimer, C., Chang, F., Pearce, M., White, M. K., Franklin, R., and Blalock, W. L. Effects of deregulated Raf and MEK1 expression on the cytokine-dependency of hematopoietic cells. Adv. Enzyme Regul., 40: 305-337, 2000.
25. Weinstein-Oppenheimer, C. R., Blalock, W. L., Steelman, L. S., Chang, F., and McCubrey, J. A. The Raf signal transduction cascade as a target for chemotherapeutic intervention in growth factor-responsive tumors. Pharmacol. Ther., 88: 229-279, 2000.
26. Blalock, W. L., Pearce, M., Steelman, L. S., Franklin, R. A., McCarthy, S. A., Cherwinski, H., McMahon, M., and McCubrey, J. A. A conditionally-active form of MEK1 results in autocrine transformation of human and mouse hematopoietic cells. Oncogene, 19: 526-536, 2000.
27. Blalock, W. L., Pearce, M., Chang, F., Lee, J. T., Pohnert, S. C., Burrows, C., Steelman, L. S., Franklin, R. A., McMahon, M., and McCubrey, J. A. Effects of inducible MEK1 activation on the cytokine dependency of lymphoid cells. Leukemia, 15: 794-807, 2001.
28. Cipl induced by Raf is associated with increased Cdk4 activity in hematopoietic cells. Oncogene, 20: 4354-4364, 2001.
29. Hoyle, P. E., Moye, P. W., Steelman, L. S., Blalock, W. L., Franklin, R. A., Pearce, M., Cherwinski, H., Bosch, E., McMahon, M., and McCubrey, J. A. Differential abilities of the Raf family of protein kinases to abrogate cytokine dependency and prevent apoptosis in murine hematopoietic cells by a MEK1-dependent mechanism. Leukemia, 14: 642-656, 2000.
30. McCubrey, J. A., May, W. S., Duronio, V., and Mufson, A. Serine/threonine phosphorylation in cytokine signal transduction. Leukemia, 14: 9-21, 2000.
31. Weinstein-Oppenheimer, C., Steelman, L. S., Algate, P. A., Blalock, W. L., Burrows, C., Hoyle, P. E., Lee, J. T., Moye, P. W., Shelton, J. G., Franklin, R., and McCubrey, J. A. Effects of deregulated Raf activation on integrin, cytokine-receptor expression and the induction of apoptosis in hematopoietic cells. Leukemia, 14: 1921-1938, 2000.
32. McCubrey, J. A., Lee, J. T., Steelman, L. S., Blalock, W. L., Moye, P. W., Chang, F., Pearce, M., Shelton, J. G., White, M. K., Franklin, R. A., and Pohnert, S. C. Interactions between the PI3K and Raf signaling pathways can result in the transformation of hematopoietic cells. Cancer Detect. Prev., 25: 375-393, 2001.
33. Cornwell, M. M., and Smith, D. E. A signal transduction pathway for activation of the mdr1 promoter involves the proto-oncogene c-raf kinase. J. Biol. Chem., 268: 15347-15350, 1993.
34. Kim, S-H., Lee, S-H., Kwak, N-H., Kang, C-D., and Chung, B-S. Effect of the activated Raf protein kinase on the human multidrug resistance 1 (MDR1) gene promoter. Cancer Lett., 98: 199-205, 1996.
35. Rasouli-Nia, A., Liu, D., Perdue, S., and Britten, R. A. High Raf-1 kinase activity protects human tumor cells against paclitaxel-induced cytotoxicity. Clin. Cancer Res., 4: 1111-1116, 1998.
36. Blalock, W. L., Moye, P. W., Chang, F., Pearce, M., Steelman, L. S., McMahon, M., and McCubrey, J. A. Combined effects of aberrant MEK1 activity and BCL2 overexpression on relieving the cytokine dependency of human and murine hematopoietic cells. Leukemia, 14: 1080-1096, 2000.
37. Moye, P. W., Blalock, W. L., Hoyle, P. E., Chang, F., Franklin, R. A., Weinstein-Oppenheimer, C., Pearce, M., Steelman, L., McMahon, M., and McCubrey, J. A. Synergy between Raf and BCL2 in abrogating the cytokine dependency of hematopoietic cells. Leukemia, 14: 1060-1079, 2000.
38. Deng, X., Ruvolo, P., Carr, B., and May, W. S., Jr. Survival function of ERK1/2 as IL-3-activated, staurosporine-resistant Bcl2 kinases. Proc. Natl. Acad. Sci. USA, 97: 1578-1583, 2000.
39. McCubrey, J., Holland, G., McKearn, J., and Risser, R. Abrogation of factor-dependence in two IL-3-dependent cell lines can occur by two distinct mechanisms. Oncogene Res., 4: 97-109, 1989.
40. McCubrey, J. A., Smith, S. R., Algate, P. A., DeVente, J. E., White, M. K., and Steelman, L. S. Retroviral infection can abrogate the factor-dependency of hematopoietic cells by autocrine and non-autocrine mechanisms depending on the presence of a functional viral oncogene. Oncogene, 8: 2905-2915, 1993.
41. Steelman, L. S., Algate, P. A., Blalock, W. L., Wang, X-Y., Prevost, K. D., Hoyle, P. E., and McCubrey, J. A. Oncogenic effects of overexpression of the interleukin-3 receptor on hematopoietic cells. Leukemia, 10: 528-542, 1996.
42. McCubrey, J. A., Steelman, L. S., Wang, X-Y., Algate, P. A., Hoyle, P. E., White, C., Davidian, E. W., Prevost, K. D., Robbins, P., Mylott, D., and White, M. K. Differential effects of viral and cellular oncogenes on the growth factor-dependency of hematopoietic cells. Int. J. Oncol., 7: 295-310, 1995.
43. Nuñez, G., London, L., Hockenbery, D., Alexander, M., McKearn, J. P., and Korsmeyer, S. J. Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines. J. Immunol., 144: 3602-3610, 1990.
44. Samuels, M. L., Weber, M. J., Bishop, J. M., and McMahon, M. Conditional transformation of cells and rapid activation of the mitogen-activated protein kinase cascade by an estradiol-dependent human raf-1 protein kinase. Mol. Cell. Biol., 13: 6241-6252, 1993.
45. Cipl. Mol. Cell. Biol., 17: 5588-5597, 1997.
46. Skehan, P., Storeng, R., Scudiero, D., Monks, A., McMahon, J., Vistica, D., Warren, J. T., Bokesch, H., Kenney, S., and Boyd, M. R. New colorimetric cytotoxicity assay for anticancer-drug screening. J. Natl. Cancer Inst. (Bethesda), 82: 1107-1112, 1990.
47. Weinstein-Oppenheimer, C. R., Henríquez-Roldán, C. F., Davis, J. M., Navolanic, P. M., Saleh, O. A., Steelman, L. S., Franklin, R. A., Robinson, P. J., McMahon, M., and McCubrey, J. A. Role of the Raf signal transduction cascade in the in vitro resistance to the anticancer drug doxorubicin. Clin. Cancer Res., 7: 2898-2907, 2001.
48. Giannakakou, P., Gussio, R., Nogales, E., Downing, K. H., Zaharevitz, D., Bollbuck, B., Poy, G., Sackett, D., Nicolaou, K. C., and Fojo, T. A common pharmacophore for epothilone and taxanes: molecular basis for drug resistance conferred by tubulin mutations in human cancer cells. Proc. Natl. Acad. Sci. USA, 97: 2904-2909, 2000.
49. Blagosklonny, M. V., Schulte, T., Nguyen, P., Trepel, J., and Neckers, L. M. Taxol-induced apoptosis and phosphorylation of Bcl-2 protein involves c-Raf-1 and represents a novel c-Raf-1 signal transduction pathway. Cancer Res., 56: 1851-1854, 1996.
50. Blagosklonny, M. V. Unwinding the loop of Bcl-2 phosphorylation. Leukemia, 15: 869-874, 2001.
51. Wilson, B. E., Mochon, E., and Boxer, L. M. Induction of bcl-2 expression by phosphorylated CREB proteins during B-cell activation and rescue from apoptosis. Mol. Cell. Biol., 16: 5546-5556, 1996.
52. Pugazhenthi, S., Miller, E., Sable, C., Young, P., Heidenreich, K. A., Boxer L. M., and Reusch, J. E-B. Insulin-like growth factor-I induces bcl-2 promoter through the transcription factor cAMP-response element-binding protein. J. Biol. Chem., 274: 27529-27535, 1999.
53. Chen, W., Yu, Y-L., Lee, S-F., Chiang, Y-J., Chao, J-R., Huang, J-H., Chiong, J-H., Huang, C-J., Lai, M-Z., Yang-Yen, H-F., and Yen, J. J-Y. CREB is one component of the binding complex of the Ces-2/E2A-HLF binding element and is an integral part of the interleukin-3 survival signal. Mol. Cell. Biol., 21: 4636-4646, 2001.
54. Pugazhenthi, S., Nesterova, A., Sable, C., Heidenreich, K. A., Boxer, L. M., Heasley, L. E., and Reusch, J. E-B. Akt/protein kinase B up-regulates Bcl-2 expression through cAMP-response element-binding protein. J. Biol. Chem., 275: 10761-10766, 2000.